Opaleye Management Inc. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 39 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 3.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2019$469,000
-39.6%
1,000,000
-60.0%
0.14%
-50.7%
Q4 2018$777,000
-57.2%
2,500,0000.0%0.29%
-37.2%
Q3 2018$1,817,000
+36.3%
2,500,000
-19.4%
0.46%
+33.9%
Q2 2018$1,333,000
-24.3%
3,100,000
-4.9%
0.34%
-31.4%
Q1 2018$1,760,000
+45.9%
3,260,000
+78.6%
0.50%
+30.3%
Q4 2017$1,206,0001,825,0000.39%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders